226 related articles for article (PubMed ID: 30058679)
21. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
[TBL] [Abstract][Full Text] [Related]
22. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
[TBL] [Abstract][Full Text] [Related]
23. Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.
Tian Y; Wu K; Liu Q; Han N; Zhang L; Chu Q; Chen Y
J Hematol Oncol; 2016 Sep; 9(1):83. PubMed ID: 27601007
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
Zeng H; Zhao X; Tang C
Cancer Chemother Pharmacol; 2021 Aug; 88(2):223-233. PubMed ID: 33907880
[TBL] [Abstract][Full Text] [Related]
25.
Nabeshima T; Hamada S; Taguchi K; Tanaka Y; Matsumoto R; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G419-G427. PubMed ID: 31961719
[TBL] [Abstract][Full Text] [Related]
26. Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers.
Goldstein LD; Lee J; Gnad F; Klijn C; Schaub A; Reeder J; Daemen A; Bakalarski CE; Holcomb T; Shames DS; Hartmaier RJ; Chmielecki J; Seshagiri S; Gentleman R; Stokoe D
Cell Rep; 2016 Sep; 16(10):2605-2617. PubMed ID: 27568559
[TBL] [Abstract][Full Text] [Related]
27. Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.
Konstantinopoulos PA; Spentzos D; Fountzilas E; Francoeur N; Sanisetty S; Grammatikos AP; Hecht JL; Cannistra SA
Cancer Res; 2011 Aug; 71(15):5081-9. PubMed ID: 21676886
[TBL] [Abstract][Full Text] [Related]
28. Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors.
Sparaneo A; Fabrizio FP; la Torre A; Graziano P; Di Maio M; Fontana A; Bisceglia M; Rossi A; Pizzolitto S; De Maglio G; Tancredi A; Grimaldi F; Balsamo T; Centra F; Manzorra MC; Trombetta D; Pantalone A; Bonfitto A; Maiello E; Fazio VM; Muscarella LA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126053
[TBL] [Abstract][Full Text] [Related]
29. Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.
Lister A; Nedjadi T; Kitteringham NR; Campbell F; Costello E; Lloyd B; Copple IM; Williams S; Owen A; Neoptolemos JP; Goldring CE; Park BK
Mol Cancer; 2011 Apr; 10():37. PubMed ID: 21489257
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and Prognostic Significance of Keap1 mRNA Expression for Lung Cancer Based on Microarray and Clinical Information from Oncomine Database.
Liu GY; Zhang W; Chen XC; Wu WJ; Wan SQ
Curr Med Sci; 2021 Jun; 41(3):597-609. PubMed ID: 34169426
[TBL] [Abstract][Full Text] [Related]
31. KEAP1/NRF2 axis regulates H
He J; Zhang X; Lian C; Wu J; Fang Y; Ye X
Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636
[TBL] [Abstract][Full Text] [Related]
32. Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival.
Wong TF; Yoshinaga K; Monma Y; Ito K; Niikura H; Nagase S; Yamamoto M; Yaegashi N
Int J Gynecol Cancer; 2011 Nov; 21(8):1428-35. PubMed ID: 21897267
[TBL] [Abstract][Full Text] [Related]
33. ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas.
Nguyen V; Schrank TP; Major MB; Weissman BE
PLoS One; 2024; 19(2):e0297741. PubMed ID: 38358974
[TBL] [Abstract][Full Text] [Related]
34. miRNA-141 attenuates UV-induced oxidative stress via activating Keap1-Nrf2 signaling in human retinal pigment epithelium cells and retinal ganglion cells.
Cheng LB; Li KR; Yi N; Li XM; Wang F; Xue B; Pan YS; Yao J; Jiang Q; Wu ZF
Oncotarget; 2017 Feb; 8(8):13186-13194. PubMed ID: 28061435
[TBL] [Abstract][Full Text] [Related]
35. Interdisciplinary Study of the Effects of Dipeptidyl-Peptidase III Cancer Mutations on the KEAP1-NRF2 Signaling Pathway.
Matić S; Tomašić Paić A; Sobočanec S; Pinterić M; Pipalović G; Martinčić M; Matovina M; Tomić S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216111
[TBL] [Abstract][Full Text] [Related]
36. A catalogue of somatic NRF2 gain-of-function mutations in cancer.
Kerins MJ; Ooi A
Sci Rep; 2018 Aug; 8(1):12846. PubMed ID: 30150714
[TBL] [Abstract][Full Text] [Related]
37. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.
Solis LM; Behrens C; Dong W; Suraokar M; Ozburn NC; Moran CA; Corvalan AH; Biswal S; Swisher SG; Bekele BN; Minna JD; Stewart DJ; Wistuba II
Clin Cancer Res; 2010 Jul; 16(14):3743-53. PubMed ID: 20534738
[TBL] [Abstract][Full Text] [Related]
38. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X
J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
[TBL] [Abstract][Full Text] [Related]
40. NRF2-Driven
Tian Y; Liu Q; Yu S; Chu Q; Chen Y; Wu K; Wang L
Mol Cancer Res; 2020 Oct; 18(10):1465-1476. PubMed ID: 32571982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
